In-depth Analysis and Data-driven Insights on the Impact of COVID-19 Included in this Global Healthcare Artificial Intelligence (AI) Market Report. The healthcare artificial intelligence market is expected to reach USD 44.
New York, Dec. 08, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report "Healthcare Artificial Intelligence (AI) Market – Global Outlook & Forecast 2021-2026" – https://www.reportlinker.com/p06188649/?utm_source=GNW
5 billion by 2026, growing at a CAGR of 46.21%.
Several pharmaceutical companies are implementing innovative technologies to boost their growth in the global healthcare industry. Collaboration of GSK with Exscientia identified a small compound for targeted therapeutics and its characteristics towards the specific target using the AI platform. AI is becoming an incredible platform in the pharmaceutical industry. For instance, Novartis announced Microsoft as a strategic partner in AI and data science to set up an AI innovation lab. Since the last year, over 50+ companies have got machine learning and AI algorithms approvals. During the COVID-19 pandemic, AI played a significant role in the healthcare industry. An analytics study by Accenture combined with clinical applications demonstrated the potential of AI to reduce approximately USD 150 billion per annum by 2026 in the US healthcare system.
The following factors are likely to contribute to the growth of the healthcare artificial intelligence market during the forecast period:
• Increase in patient volume & complexities associated with data fueling demand for AI.
• The shrinking operational workforce in healthcare facilities propelling the need for AI.
• Technological advancement & innovations in AI influencing end-users in the market.
• Rising Investment in advanced drug discovery & development process augmenting the adoption of AI.
• The healthcare providers segment accounted for the largest market share with around 48% compared to others in 2020.
• According to the research, Arizton estimated that APAC would witness the highest growth in the healthcare artificial intelligence (AI) market during the forecast period.
The study considers a detailed scenario of the present healthcare artificial intelligence market and its market dynamics for the period 2021?2026. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the market.
HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET SEGMENTATION
This research report includes a detailed segmentation by
HEALTHCARE ARTIFICIAL INTELLIGENCE (AI) MARKET SEGMENTS
The software industry provides numerous services to the healthcare industry. With the advent of medical software, human errors are minimized in the global medical market. Using advanced software in healthcare enables the clinical experts to expertise their practices. Software providers are gaining huge opportunities in the healthcare artificial intelligence (AI) market. Software development companies are constantly striving to improve the industry and bring innovations.
Market Segmentation by Application
• Hospital Workflow Management
• Medical Imaging and Diagnosis
• Drug Discovery and Precision Medicine
• Patient Management
Market Segmentation by Technology
• Machine Learning
• Querying Method
• Natural Language Processing
Market Segmentation by End-users
• Healthcare Providers
• Pharma-biotech and medical devices companies
US is the major revenue generator of the healthcare artificial intelligence (AI) market across the North American region. In North America, the potential increase in AI GDP is compounded by tremendous opportunities to adopt more productive technologies.
Market Segmentation by Geography
• North America
o Nordic Countries
o Japan, Australia
o South Korea
o Rest of APAC
• Latin America
• Middle East & Africa
o Saudi Arabia
o South Africa
Giant players are focusing on pursuing organic growth strategies to enhance their product portfolio in the healthcare artificial intelligence (AI) market. Several initiatives by the players will complement growth strategies, which are gaining traction among end-users in the market. Rising growth of startups collaborating with key vendors in promoting their artificial intelligence in healthcare applications creating heavy competition in the market.
• IBM (International Business Machines)
• Intel Corporation
• Microsoft Corporation
• Nvidia Corporation
• Siemens Healthineers
Other Prominent Vendors
• Caption Health
• Catalia Health
• General Vision
• Shimadzu Recursion Pharmaceuticals
• GE Healthcare
• Remedy Medical
• Subtle Medical
• Netbase Quid
• Oncora Medical
• Qure.AI Technologies
• Anju software
• Imagia Cybernetics
• Deep Genomics
• Welltok Inc.
• MaxQ AI
KEY QUESTIONS ANSWERED:
1. How big is the healthcare artificial intelligence (AI) market?
2. Which region has the highest share in the healthcare artificial intelligence market?
3. Who are the key players in the healthcare AI market?
4. What are the latest market trends in the healthcare artificial intelligence market?
5. What is the use of AI in the healthcare market?
Read the full report: https://www.reportlinker.com/p06188649/?utm_source=GNW
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.
The market is experiencing a major loss of confidence in software maker Everbridge (NASDAQ: EVBG), the self-proclaimed "global leader in critical event management." One analyst bit the bullet and went all the way to underperform on Everbridge: Bank of America's Brad Sills. On Thursday night, Everbridge abruptly announced that CEO David Meredith had told the board of directors that he intended to resign, and the board had accepted his resignation.
Shares of fintech powerhouse Square (NYSE: SQ) had dipped 3% as of noon ET on Friday, despite receiving a generally positive endorsement from investment bank Jefferies today. In a note covered on TheFly.com today, Jefferies argues that Square stock is a buy and deserves a target of $240 per share, because all the bad news from Square's November earnings report is now baked into the price, and the stock looks "catalyst-rich in 2022." The bad news: Jefferies thinks that monthly active users of Square's Cash App are growing more slowly than previously expected, and points to "commentary from management" indicating a downside in the growth rate in the fourth quarter of 2021.
As of 10:15 a.m. ET, Figs shares had declined by 16% to the lowest level since it went public in May. CFO Jeffrey Lawrence announced his intention to retire, effective Dec. 24. Lawrence came out of retirement in December 2020 to lead Figs' financial house through its initial public offering (IPO).
In this article, we discuss the 10 new stocks Reddit’s WallStreetBets is buying. If you want to skip our detailed analysis of these stocks, go directly to 5 New Stocks Reddit’s WallStreetBets is Buying. Internet platform Reddit became perhaps the single most disruptive force at the stock market this year as retail investors use the […]
If these companies' growth prospects were good enough before the omicron-fueled rout, they're even better now.
The Dow Jones Industrial Average is an index made up of 30 of the largest and most influential companies on U.S. stock exchanges. Not every stock in the Dow Jones has performed well. Biotech company Amgen (NASDAQ: AMGN) has been down about 7% since the beginning of 2021.
Extending their 6% slide down yesterday, shares of fuel cell specialist Plug Power (NASDAQ: PLUG) are continuing to plunge today. Plug Power announced after the market closed yesterday that it had completed the acquisition of Frames Group — a deal that had been announced in early November. According to Plug Power, Frames Group "designs, builds, and delivers processing equipment, separation technologies, flow control and safeguarding systems, for water and renewable energy solutions."
It's a cliche to say that certain stocks are like roller coaster rides, but the coronavirus vaccine developer Novavax (NASDAQ: NVAX) has given a completely new meaning to the term over the last 12 months. While it's up more than 64% this year, in the last three months shareholders have taken losses of about 27%, which means that many of the people who bought shares at the peak early this year are likely to be displeased.
A legendary name has just bought a whole lot more of Ford's stock.
Peloton shares get hammered again due to a surprising plot twist in the new Sex and the City
The gains were driven by a 6% rise in cloud services and license support revenue, to $7.6 billion, and a 13% jump in cloud license and on-premise license revenue, to $1.2 billion. Notably, sales growth in Oracle's infrastructure and applications cloud businesses checked in at an impressive 22%. Oracle's enterprise resource planning (ERP) and next-generation cloud infrastructure solutions are enjoying particularly strong demand.
All investors should develop some sort of mental checklist when picking stocks to buy. I personally look for companies with a large and growing addressable market, strong revenue growth, and a business that can scale into more profitability over time.
Yahoo Finance Live details the first day of trading for Nubank, the largest financial technology bank in Latin America, on the New York Stock Exchange.
Most investors likely know three things about Sea Limited (NYSE: SE): that it owns Shopee, the top e-commerce player in Southeast Asia and Taiwan; that it owns the mobile game publisher Garena; and that it is deeply unprofitable. Four years ago, Garena launched Free Fire, its first self-developed mobile game.
A decade ago, smartphones and electric cars were barely a thing. Now, if you bought Apple or Tesla (NASDAQ: TSLA) stock a decade ago, it's worked out very well for you. Crowdstrike Holdings (NASDAQ: CRWD) uses its proprietary "Falcon" platform to link all its customers together on a cloud-based network.
Legendary short-seller Jim Chanos has revealed that he is short shares of DraftKings (NASDAQ: DKNG). Note, shorting a stock means you are betting that its shares will go down in value. Chanos cites DraftKings' aggressive spending on marketing and the stock's rich valuation as the main reasons he is short the stock.
Stock market futures pushed modestly higher on Friday morning, positioning Wall Street for a favorable end to what's been a tumultuous but strongly positive week. As of 8:15 a.m. ET, Nasdaq Composite (NASDAQINDEX: ^IXIC) futures were up 35 points to 16,183. On Friday morning, though, there was a lot to celebrate in the tech space, as favorable news from Broadcom (NASDAQ: AVGO) and C3.ai (NYSE: AI) sent their respective shares sharply higher.
The big shareholder groups in Grab Holdings Limited ( NASDAQ:GRAB ) have power over the company. Institutions will…
Investing in stocks comes with the risk that the share price will fall. And unfortunately for Skillz Inc. ( NYSE:SKLZ…
Shares of Mesa Air Group (NASDAQ: MESA) traded down 20% on Friday morning in response to the airline's earnings report. Costs are weighing on results, and Wall Street is worried those headwinds won't subside anytime soon. After markets closed Thursday, Mesa reported a fiscal fourth-quarter loss of $0.06 per share on revenue of $130.78 million.